Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026
Go back to Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026| Asianada, Inc. (NASDAQ: ASND) | Delayed: 242.97 +4.07 (1.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $238.90 | 52 Week High | $21.79 | |||
| Open | $239.38 | 52 Week Low | $11.92 | |||
| Day High | $243.26 | P/E | N/A | |||
| Day Low | $236.87 | EPS | $-0.07 | |||
| Volume | 301,210 | |||||



